STOCK TITAN

Applied Molecular Transport to Present at Canaccord Genuity’s 41st Annual Growth Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Applied Molecular Transport (Nasdaq: AMTI) announced that CEO Tahir Mahmood will participate in a fireside chat at Canaccord Genuity’s 41st Annual Growth Conference on August 11, 2021, at 2:30 p.m. ET. A live webcast will be available on the company’s website, with an archived replay accessible for 30 days post-event.

AMT is a clinical-stage biopharmaceutical firm focused on developing oral biologic product candidates for autoimmune and inflammatory diseases using its proprietary technology platform.

Positive
  • None.
Negative
  • None.

SOUTH SAN FRANCISCO, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during Canaccord Genuity’s 41st Annual Growth Conference on Wednesday, August 11, 2021 at 2:30 p.m. ET.

A live webcast will be accessible via the Events page of the Applied Molecular Transport website at https://ir.appliedmt.com/news-events/events. An archived replay will be available for 30 days following the event.

About Applied Molecular Transport Inc.

Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. AMT’s proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of diverse therapeutic modalities across the intestinal epithelial (IE) barrier. Active transport is an efficient mechanism that uses the cell’s own machinery to transport materials across the IE barrier. AMT believes that its ability to exploit this mechanism is a key differentiator of its approach. AMT is developing additional oral biologic product candidates in patient-friendly oral forms that are designed to either target local gastrointestinal tissue or enter systemic circulation to precisely address the relevant biology of a disease.

AMT’s headquarters, internal GMP manufacturing and lab facilities are located in South San Francisco, CA. For additional information on AMT, please visit www.appliedmt.com.

Investor Relations Contact:
Andrew Chang
Head, Investor Relations & Corporate Communications
achang@appliedmt.com

Media Contacts:
Alexandra Santos
Wheelhouse Life Science Advisors
asantos@wheelhouselsa.com

Aljanae Reynolds
Wheelhouse Life Science Advisors
areynolds@wheelhouselsa.com


FAQ

What is the date and time of Tahir Mahmood's fireside chat?

Tahir Mahmood's fireside chat is scheduled for August 11, 2021, at 2:30 p.m. ET.

Where can I watch the live webcast of the Canaccord Genuity conference?

The live webcast can be accessed via the Events page on the Applied Molecular Transport website.

What is the focus of Applied Molecular Transport Inc.?

Applied Molecular Transport focuses on developing oral biologic product candidates to treat autoimmune, inflammatory, and metabolic diseases.

What is the ticker symbol for Applied Molecular Transport?

The ticker symbol for Applied Molecular Transport is AMTI.

How long will the replay of the fireside chat be available?

The replay of the fireside chat will be available for 30 days after the event.

Applied Molecular Transport Inc.

NASDAQ:AMTI

AMTI Rankings

AMTI Latest News

AMTI Stock Data

11.01M
33.72M
21.36%
37.28%
0.47%
Biotechnology
Healthcare
Link
United States
South San Francisco